Skip to main content

Published locations for Risankizumab impresses in phase 2 psoriatic arthritis trial

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Risankizumab impresses in phase 2 psoriatic arthritis trial

User login

  • Reset your password
  • /content/risankizumab-impresses-phase-2-psoriatic-arthritis-trial
  • /edermatologynews/article/168813/psoriatic-arthritis/risankizumab-impresses-phase-2-psoriatic
  • /internalmedicinenews/article/168813/psoriatic-arthritis/risankizumab-impresses-phase-2-psoriatic
  • /rheumatologynews/article/168813/psoriatic-arthritis/risankizumab-impresses-phase-2-psoriatic
  • /rheumatology/article/168813/psoriatic-arthritis/risankizumab-impresses-phase-2-psoriatic-arthritis
  • /internalmedicine/article/168813/psoriatic-arthritis/risankizumab-impresses-phase-2-psoriatic
  • /dermatology/article/168813/psoriatic-arthritis/risankizumab-impresses-phase-2-psoriatic-arthritis
  • /rheumatology/psoriatic-arthritis-resource-center/article/168813/psoriatic-arthritis/risankizumab
  • /dermatology/psoriasiscollection/article/168813/psoriatic-arthritis/risankizumab-impresses-phase-2
  • /psoriatic-arthritis-icymi/article/168813/psoriatic-arthritis/risankizumab-impresses-phase-2